FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Lithium Carbonate Capsules
Status: Discontinuation
»Therapeutic Categories: Psychiatry

Expand all

Mylan Pharmaceuticals Inc. (New 12/12/2017)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
Lithium Carbonate Capsules, 150 mg (NDC 0143-3188-01) 12/12/2017 Discontinuation of the manufacture of the drug product.
Lithium Carbonate Capsules, 300 mg (NDC 0143-3189-01) (NDC 0143-3189-10) 12/12/2017 Discontinuation of the manufacture of the drug product.
Lithium Carbonate Capsules, 600 mg (NDC 0143-3190-01) 12/12/2017 Discontinuation of the manufacture of the drug product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English